Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /ZIMLAB

ZIM Laboratories Ltd.

ZIMLAB

• NSE: ZIMLAB • Delayed

87.94INR 3.1%

0.9220 USD

As of 6 June 2026, ZIM Laboratories Ltd. has a market cap of $47.37M USD, ranking #30965 globally and #1997 in India. It ranks #2796 in the Healthcare sector, and #165 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

30965

Country Rank

1997

Sector Rank

2796

Industry Rank

165

Key Stats

Market Cap

$47.37MUSD

4.54B INR

Enterprise Value

$59.96MUSD

5.72B INR

Revenue (TTM)

$39.47MUSD

3.78B INR

EBITDA (TTM)

$3.6MUSD

343.84M INR

Net Income (TTM)

$729.28KUSD

69.83M INR

EBITDA Margin

9.1%

Profit Margin

1.8%

PE Ratio

65.0

PS Ratio

1.2

PB Ratio

1.8

EV/EBITDA

14.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Anwar Daud open_in_new

Employees

577

Founded

1984

Website

zimlab.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.1%	1.3%	34%	14%	24%	18%	-2.4%	8.3%	-6.1%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	ZIMLAB Zim Laboratories Ltd Ordinary Shares ISIN: INE518E01015 Shares Out.: Shares Outstanding: 53.549M¹ Shares Float: 46.324M² TV: TradingView: NSE: ZIMLAB SA: Stock Analysis: NSE: ZIMLAB YF: Yahoo Finance: ZIMLAB.NS GF: Google Finance: NSE: ZIMLAB BA: Barron's: ZIMLAB MS: Morningstar: XNSE: ZIMLAB	87.94 INR	TV: TradingView: NSE: ZIMLAB SA: Stock Analysis: NSE: ZIMLAB YF: Yahoo Finance: ZIMLAB.NS GF: Google Finance: NSE: ZIMLAB BA: Barron's: ZIMLAB MS: Morningstar: XNSE: ZIMLAB
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	541400 (ZIMLAB) Zim Laboratories Ltd Ordinary Shares ISIN: INE518E01015 TV: TradingView: BSE: ZIMLAB SA: Stock Analysis: BOM: 541400 YF: Yahoo Finance: 541400.BO GF: Google Finance: BOM: 541400 BA: Barron's: 541400 MS: Morningstar: XBOM: 541400	84.70 INR	TV: TradingView: BSE: ZIMLAB SA: Stock Analysis: BOM: 541400 YF: Yahoo Finance: 541400.BO GF: Google Finance: BOM: 541400 BA: Barron's: 541400 MS: Morningstar: XBOM: 541400

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ZIM Laboratories Ltd.

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 23K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 23K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 18K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.87B 178.87B INR 4K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 4K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$944.92M 90.48B INR 2K%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 79K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 62K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 33K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 19K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 18K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 11K%	20.0	China

chevron_leftBack